SCHEMBL2537574

SCHEMBL2537574

O=C(O)OC(=O)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
TDP1 Q9NUW8 2/20 0.57
KMT2A Q03164 2/20 0.57
MAPK1 P28482 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
SLC6A2 P23975 1/20 0.57
SLC6A3 Q01959 1/20 0.57
LMNA P02545 3/20 0.52
HCAR2 Q8TDS4 1/20 0.52
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MEN1 O00255 1/20 0.46
HTT P42858 1/20 0.46
GFER P55789 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48133 0.91 ALDH1A1 (0.63) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL10459697 0.89 ALDH1A1 (0.61) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL28207255 0.88 ALDH1A1 (0.59) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL37382 0.87 ALDH1A1 (0.68) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
Water SCHEMBL8217838 0.85 ALDH1A1 (0.65) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
Ammonia Solution, Strong SCHEMBL9998884 0.85 ALDH1A1 (0.65) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
Bicarbonate SCHEMBL29183459 0.85 ALDH1A1 (0.65) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL1970462 0.84 ALDH1A1 (0.71) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL11654186 0.84 ALDH1A1 (0.71) ALDH1A1TDP1KMT2AMAPK1L3MBTL1
SCHEMBL550350 0.84 ALDH1A1 (0.55) ALDH1A1TDP1KMT2AMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032585-B1 DEOXYHYPUSINE REAGENT AND PEPTIDES UNIV FLORIDA (US) 2004-11-24 EP claimed
US-6586135-B2 Dicarbonate compound such as dibenzyl dicarbonate mixed with either the anode material or the cathode active material prior to contact with its current collector WILSON GREATBACH LTD. 2003-07-01 US claimed
EP-0951085-B1 Dicarbonate additives for non-aqueous electrolyte in alkali metal electrochemical cells GREATBATCH W LTD (US) 2003-01-29 EP claimed
US-20020136949-A1 Electrochemical cell having an electrode with a dicarbonate additive in the electrode active mixture GREATBATCH, INC. 2002-09-26 US claimed
EP-1244159-A1 Electrochemical cell having an electrode with a dicarbonate additive in the electrode active mixture WILSON GREATBATCH LTD. (US) 2002-09-25 EP claimed
WO-2002004417-A1 PROCESS FOR THE PREPARATION OF DERIVATIVES OF 4-AMINO-3-HYDROXYPYRROLE-2-CARBOXYLIC ACID PHARMACIA CORPORAION (US) 2002-01-17 WO claimed
US-6174629-B1 ADDITION OF AT LEAST ONE DICARBONATE ADDITIVE TO AN ELECTROLYTE COMPRISING AN ALKALI METAL SALT DISSOLVED IN A SOLVENT MIXTURE THAT INCLUDES ETHYLENE CARBONATE, DIMETHYL CARBONATE, ETHYL METHYL CARBONATE AND DIETHYL CARBONATE WILSON GREATBATCH LTD. 2001-01-16 US claimed
EP-1005098-A2 Alkali metal electrochemical cell having an improved cathode activated with a nonaqueous electrolyte having a passivation inhibitor additive WILSON GREATBATCH LTD. (US) 2000-05-31 EP claimed
US-6063526-A AN ALKALI METAL, SOLID CATHODE, NONAQUEOUS ELECTROCHEMICAL CELL CAPABLE OF DELIVERING HIGH CURRENT PULSES, RAPIDLY RECOVERING ITS OPEN CIRCUIT VOLTAGE AND HAVING HIGH CURRENT CAPACITY; USE IN MEDICAL DEVICES SUCH AS DEFIBRILLATORS WILSON GREATBATCH LTD. (US) 2000-05-16 US claimed
EP-0951085-A1 Dicarbonate additives for non-aqueous electrolyte in alkali metal electrochemical cells WILSON GREATBATCH LTD. (US) 1999-10-20 EP claimed
US-20180179378-A1 Copolycarbonate Compositions with Cyclic and Linear Oligomers and Improved Optical Properties COVESTRO DEUTSCHLAND AG (DE) 2018-06-28 US disclosed
EP-1734082-B1 MONOAZO/IRON COMPLEX COMPOUND, CHARGE CONTROL AGENT COMPRISING THE SAME, AND TONER HODOGAYA CHEMICAL CO LTD (JP) 2011-10-19 EP disclosed
WO-2010065310-A1 INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE VIA PHARMACEUTICALS, INC (US) 2010-06-10 WO disclosed
US-7402369-B2 Mono azo iron complex compound, and charge controlling agent and toner using the same HODOGAYA CHEMICAL CO., LTD. (JP) 2008-07-22 US disclosed
US-20070020547-A1 Mono azo iron complex compound, and charge controlling agent and toner using the same HODOGAYA CHEMICAL CO., LTD. 2007-01-25 US disclosed
US-6174629-B1 ADDITION OF AT LEAST ONE DICARBONATE ADDITIVE TO AN ELECTROLYTE COMPRISING AN ALKALI METAL SALT DISSOLVED IN A SOLVENT MIXTURE THAT INCLUDES ETHYLENE CARBONATE, DIMETHYL CARBONATE, ETHYL METHYL CARBONATE AND DIETHYL CARBONATE WILSON GREATBATCH LTD. 2001-01-16 US disclosed
EP-1005098-A2 Alkali metal electrochemical cell having an improved cathode activated with a nonaqueous electrolyte having a passivation inhibitor additive WILSON GREATBATCH LTD. (US) 2000-05-31 EP disclosed
US-6063526-A AN ALKALI METAL, SOLID CATHODE, NONAQUEOUS ELECTROCHEMICAL CELL CAPABLE OF DELIVERING HIGH CURRENT PULSES, RAPIDLY RECOVERING ITS OPEN CIRCUIT VOLTAGE AND HAVING HIGH CURRENT CAPACITY; USE IN MEDICAL DEVICES SUCH AS DEFIBRILLATORS WILSON GREATBATCH LTD. (US) 2000-05-16 US disclosed
EP-0951085-A1 Dicarbonate additives for non-aqueous electrolyte in alkali metal electrochemical cells WILSON GREATBATCH LTD. (US) 1999-10-20 EP disclosed
US-4960881-A REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1990-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070020547-A1 Mono azo iron complex compound, and charge controlling agent and toner using the same CA2, ASH2L, SLC40A1 ALDH1A1 3611/4885TDP1 2598/4885KMT2A 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.